{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:56:49Z","timestamp":1790017009969,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["126"],"award-info":[{"award-number":["126"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00432-019-03039-2","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T08:02:41Z","timestamp":1570262561000},"page":"3125-3135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["\u201cRisk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation\u201d"],"prefix":"10.1007","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-9385","authenticated-orcid":false,"given":"Neval E.","family":"Wareham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sengel\u00f8v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caspar","family":"Da Cunha-Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Perch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Schwartz","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"3039_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32249","author":"T Aagaard","year":"2019","unstructured":"Aagaard T, Reekie J, Roen A, Daugaard G, Specht L, Sengelov H et al (2019) Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: the (CSR) FENCE score. Int J Cancer. \nhttps:\/\/doi.org\/10.1002\/ijc.32249","journal-title":"Int J Cancer"},{"issue":"7","key":"3039_CR2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","volume":"89","author":"J Adami","year":"2003","unstructured":"Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B et al (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89(7):1221\u20131227","journal-title":"Br J Cancer"},{"issue":"13","key":"3039_CR3","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","volume":"27","author":"KH Allin","year":"2009","unstructured":"Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27(13):2217\u20132224","journal-title":"J Clin Oncol"},{"issue":"7","key":"3039_CR4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ijc.30194","volume":"139","author":"KH Allin","year":"2016","unstructured":"Allin KH, Bojesen SE, Nordestgaard BG (2016) Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population. Int J Cancer 139(7):1493\u20131500","journal-title":"Int J Cancer"},{"issue":"2","key":"3039_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7182\/pit2015826","volume":"25","author":"K Billups","year":"2015","unstructured":"Billups K, Neal J, Salyer J (2015) Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant 25(2):182\u2013188","journal-title":"Prog Transplant"},{"issue":"2","key":"3039_CR6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jiy442","volume":"219","author":"AH Borges","year":"2019","unstructured":"Borges AH, Neuhaus J, Sharma S, Neaton JD, Henry K, Anagnostou O et al (2019) The effect of interrupted\/deferred antiretroviral therapy on disease risk: a smart and start combined analysis. J Infect Dis 219(2):254\u2013263","journal-title":"J Infect Dis"},{"key":"3039_CR7","first-page":"1","volume":"82","author":"NE Breslow","year":"1987","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II\u2013The design and analysis of cohort studies. IARC Sci Publ 82:1\u2013406","journal-title":"IARC Sci Publ"},{"issue":"5","key":"3039_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"16","key":"3039_CR9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1200\/JCO.2009.27.0454","volume":"28","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR et al (2010) C-reactive protein and risk of lung cancer. J Clin Oncol 28(16):2719\u20132726","journal-title":"J Clin Oncol"},{"issue":"1","key":"3039_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2014.523","volume":"112","author":"SH Chien","year":"2015","unstructured":"Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW, Shen CC et al (2015) Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study. Br J Cancer 112(1):177\u2013184","journal-title":"Br J Cancer"},{"issue":"2","key":"3039_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","volume":"16","author":"AE Coghill","year":"2016","unstructured":"Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM (2016) Immunosuppressive Medications and Squamous Cell Skin Carcinoma: nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. Am J Transplant 16(2):565\u2013573","journal-title":"Am J Transplant"},{"issue":"8","key":"3039_CR12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","volume":"10","author":"D Collett","year":"2010","unstructured":"Collett D, Mumford L, Banner NR, Neuberger J, Watson C (2010) Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 10(8):1889\u20131896","journal-title":"Am J Transplant"},{"issue":"7","key":"3039_CR13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073\u20131081","journal-title":"Carcinogenesis"},{"issue":"13","key":"3039_CR14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","volume":"336","author":"RE Curtis","year":"1997","unstructured":"Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al (1997) Solid cancers after bone marrow transplantation. N Engl J Med 336(13):897\u2013904","journal-title":"N Engl J Med"},{"issue":"12","key":"3039_CR15","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s10096-017-3072-y","volume":"36","author":"C Ekenberg","year":"2017","unstructured":"Ekenberg C, Lodding IP, Wareham NE, Sorensen SS, Sengelov H, Gustafsson F et al (2017) Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable? Eur J Clin Microbiol Infect Dis 36(12):2391\u20132398","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"17","key":"3039_CR16","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891\u20131901","journal-title":"JAMA"},{"issue":"2","key":"3039_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10549-015-3671-1","volume":"155","author":"H Frydenberg","year":"2016","unstructured":"Frydenberg H, Thune I, Lofterod T, Mortensen ES, Eggen AE, Risberg T et al (2016) Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. Breast Cancer Res Treat 155(2):345\u2013354","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"3039_CR18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2017.96","volume":"116","author":"S Ghuman","year":"2017","unstructured":"Ghuman S, Van HM, Garmo H, Holmberg L, Malmstrom H, Lambe M et al (2017) Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer 116(10):1358\u20131365","journal-title":"Br J Cancer"},{"issue":"2","key":"3039_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.seminoncol.2014.12.029","volume":"42","author":"AE Grulich","year":"2015","unstructured":"Grulich AE, Vajdic CM (2015) The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol 42(2):247\u2013257","journal-title":"Semin Oncol"},{"issue":"1","key":"3039_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/07853890.2016.1232860","volume":"49","author":"Y Herishanu","year":"2017","unstructured":"Herishanu Y, Polliack A, Shenhar-Tsarfaty S, Weinberger R, Gelman R, Ziv-Baran T et al (2017) Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia. Ann Med 49(1):75\u201382","journal-title":"Ann Med"},{"issue":"6719","key":"3039_CR21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","volume":"397","author":"M Hojo","year":"1999","unstructured":"Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M et al (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397(6719):530\u2013534","journal-title":"Nature"},{"issue":"5","key":"3039_CR22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ijc.30531","volume":"140","author":"M Hortlund","year":"2017","unstructured":"Hortlund M, Arroyo Muhr LS, Storm H, Engholm G, Dillner J, Bzhalava D (2017) Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer 140(5):1091\u20131101","journal-title":"Int J Cancer"},{"issue":"4","key":"3039_CR23","doi-asserted-by":"crossref","first-page":"ofz086","DOI":"10.1093\/ofid\/ofz086","volume":"6","author":"EE Ilett","year":"2019","unstructured":"Ilett EE, Helleberg M, Reekie J, Murray DD, Wulff SM, Khurana MP et al (2019) Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Open Forum Infect Dis 6(4):ofz086","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"3039_CR24","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/ndt\/gfp425","volume":"25","author":"A Ingvar","year":"2010","unstructured":"Ingvar A, Smedby KE, Lindelof B, Fernberg P, Bellocco R, Tufveson G et al (2010) Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 25(8):2764\u20132771","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3039_CR25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ijc.29868","volume":"138","author":"M Izano","year":"2016","unstructured":"Izano M, Wei EK, Tai C, Swede H, Gregorich S, Harris TB et al (2016) Chronic inflammation and risk of colorectal and other obesity-related cancers: the health, aging and body composition study. Int J Cancer 138(5):1118\u20131128","journal-title":"Int J Cancer"},{"issue":"1","key":"3039_CR26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","volume":"117","author":"NS Majhail","year":"2011","unstructured":"Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM et al (2011) Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 117(1):316\u2013322","journal-title":"Blood"},{"issue":"10","key":"3039_CR27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/pros.22820","volume":"74","author":"SC Markt","year":"2014","unstructured":"Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K et al (2014) Genetic variation across C-reactive protein and risk of prostate cancer. Prostate 74(10):1034\u20131042","journal-title":"Prostate"},{"issue":"2","key":"3039_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/leu.2014.203","volume":"29","author":"AS Nelson","year":"2015","unstructured":"Nelson AS, Ashton LJ, Vajdic CM, Le Marsney RE, Daniels B, Nivison-Smith I et al (2015) Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia 29(2):441\u2013447","journal-title":"Leukemia"},{"issue":"7","key":"3039_CR29","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/1055-9965.EPI-16-1005","volume":"26","author":"SH Nelson","year":"2017","unstructured":"Nelson SH, Brasky TM, Patterson RE, Laughlin GA, Kritz-Silverstein D, Edwards BJ et al (2017a) The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women\u2019s Health Initiative. Cancer Epidemiol Biomarkers Prev 26(7):1100\u20131106","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"3039_CR30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/pbc.26219","volume":"64","author":"AS Nelson","year":"2017","unstructured":"Nelson AS, Vajdic CM, Ashton LJ, Le Marsney RE, Nivison-Smith I, Wilcox L et al (2017b) Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases. Pediatr Blood Cancer 64(1):197\u2013202","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3039_CR31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PPO.0b013e31823e5387","volume":"17","author":"MM Pomerantz","year":"2011","unstructured":"Pomerantz MM, Freedman ML (2011) The genetics of cancer risk. Cancer J 17(6):416\u2013422","journal-title":"Cancer J"},{"issue":"2","key":"3039_CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1158\/1055-9965.EPI-10-1146","volume":"20","author":"AE Prizment","year":"2011","unstructured":"Prizment AE, Anderson KE, Visvanathan K, Folsom AR (2011) Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev 20(2):297\u2013307","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"3039_CR33","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1600-6143.2011.03589.x","volume":"11","author":"CM Proby","year":"2011","unstructured":"Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L et al (2011) A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 11(7):1498\u20131508","journal-title":"Am J Transplant"},{"issue":"10105","key":"3039_CR34","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ (2017) Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390(10105):1833\u20131842","journal-title":"Lancet"},{"issue":"11","key":"3039_CR35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","volume":"20","author":"O Ringden","year":"2014","unstructured":"Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D et al (2014) Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant 20(11):1777\u20131784","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"3039_CR36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","volume":"113","author":"JD Rizzo","year":"2009","unstructured":"Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O et al (2009) Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113(5):1175\u20131183","journal-title":"Blood"},{"issue":"5","key":"3039_CR37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbmt.2016.01.027","volume":"22","author":"CM Vajdic","year":"2016","unstructured":"Vajdic CM, Mayson E, Dodds AJ, O\u2019Brien T, Wilcox L, Nivison-Smith I et al (2016) Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: a Population-Based Cohort Study. Biol Blood Marrow Transplant 22(5):949\u2013956","journal-title":"Biol Blood Marrow Transplant"},{"issue":"340","key":"3039_CR38","doi-asserted-by":"crossref","first-page":"c570","DOI":"10.1136\/bmj.c570","volume":"11","author":"MT van Leeuwen","year":"2010","unstructured":"van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J et al (2010) Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ 11(340):c570","journal-title":"BMJ"},{"key":"3039_CR39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00432-018-2674-9","volume":"144","author":"NE Wareham","year":"2018","unstructured":"Wareham NE, Mocroft A, Sengelov H, da Cunha-Bang C, Gustafsson F, Heilmann C et al (2018a) The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. J Cancer Res Clin Oncol 144:1569\u20131580","journal-title":"J Cancer Res Clin Oncol"},{"issue":"29","key":"3039_CR40","doi-asserted-by":"crossref","first-page":"e11564","DOI":"10.1097\/MD.0000000000011564","volume":"97","author":"NE Wareham","year":"2018","unstructured":"Wareham NE, Da Cunha-Bang C, Borges AH, Ekenberg C, Gerstoft J, Gustafsson F et al (2018b) Classification of death causes after transplantation (CLASS): evaluation of methodology and initial results. Medicine (Baltimore) 97(29):e11564","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"3039_CR41","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2007.01908.x","volume":"7","author":"AC Webster","year":"2007","unstructured":"Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR (2007) Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant 7(9):2140\u20132151","journal-title":"Am J Transplant"},{"issue":"1","key":"3039_CR42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ajt.12969","volume":"15","author":"EL Yanik","year":"2015","unstructured":"Yanik EL, Gustafson SK, Kasiske BL, Israni AK, Snyder JJ, Hess GP et al (2015) Sirolimus use and cancer incidence among US kidney transplant recipients. Am J Transplant 15(1):129\u2013136","journal-title":"Am J Transplant"},{"issue":"35","key":"3039_CR43","doi-asserted-by":"crossref","first-page":"23665","DOI":"10.1074\/jbc.M804047200","volume":"283","author":"B Yuan","year":"2008","unstructured":"Yuan B, Wang Y (2008) Mutagenic and cytotoxic properties of 6-thioguanine, S6-methylthioguanine, and guanine-S6-sulfonic acid. J Biol Chem 283(35):23665\u201323670","journal-title":"J Biol Chem"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-03039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-03039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-03039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:23:09Z","timestamp":1604449389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-03039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-03039-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The research is conducted after approval of the National Data Protection Agency (2012-58-0004; RH-2016\u201347; 04433) and the Danish National Board of Health (3-3013-1060\/1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All relevant approval for this project was obtained from the Danish Health and Medicines Authorities according to Danish legislation on retrospective studies. For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}